public offerings

Twenty-four months ago, CFO Mark Guerin had a pretty clear notion of what he wanted Onconova's financial footing to look like during the second half of 2019. However, the question that lingered was whether the plan that Guerin and his team were putting into motion had the vigor to overcome the obstacles along the way.…